OAB-054: Comparative efficacy of teclistamab versus real-world physician’s choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma
Titel:
OAB-054: Comparative efficacy of teclistamab versus real-world physician’s choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma
Auteur:
van de Donk, Niels W.C.J. Moreau, Philippe Delforge, Michel Einsele, Hermann Ghilotti, Francesca Diels, Joris Elsada, Ahmed Strulev, Vadim Pei, Lixia Kobos, Rachel Smit, Jennifer Marshall, Alexander Slavcev, Mary Weisel, Katja Mateos, María-Victoria